August 19, 2024 02:50 PM EDTUpdated August 20, 11:15 AM
Pharma

Half of IRA ne­go­ti­a­tion sav­ings to come from three drugs, Brook­ings finds

Zachary Brennan

Senior Editor

For the first 10 drug prices ne­go­ti­at­ed un­der the In­fla­tion Re­duc­tion Act, about one-half of the es­ti­mat­ed $6 bil­lion in Medicare sav­ings is the re­sult …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

In sur­prise, study sug­gests Covid mR­NA vac­cines may boost can­cer im­munother­a­py ef­fi­ca­cy

Pfiz­er tees up Phase 3 test in weight man­age­ment — but in an un­ex­pect­ed area

Ex-Kite lead­ers step in at Kyver­na as CEO ex­its af­ter land­ing year's sec­ond-biggest IPO

BioN­Tech rolls out Phase 2 lung can­cer da­ta as VEGF bis­pecifics take cen­ter stage

Im­mat­ics los­es Bris­tol My­er­s' sup­port on Phase 1 bis­pe­cif­ic T cell en­gager

sponsored

Break­ing down si­los with a new quan­ti­ta­tive ap­proach to drug de­vel­op­ment

A service from the Financial Times